Disclosures for "Enabling Opioid Dose Reduction for Refractory Restless Legs Syndrome through Adjunctive Tonic Motor Activation (TOMAC) Therapy")
-
Mark Buchfuhrer has nothing to disclose.
-
Miss Rodriguez has nothing to disclose.
-
Dr. Charlesworth has received personal compensation for serving as an employee of Noctrix Health, Inc.. Dr. Charlesworth has stock in Noctrix Health, Inc.. The institution of Dr. Charlesworth has received research support from NIH (NINDS). Dr. Charlesworth has received intellectual property interests from a discovery or technology relating to health care.